Neonatal Anemia

Kendell   R.   German; Sandra   E.   Juul
doi:10.2174/1573396319666221121140627
Abstract

All neonates experience a downtrend in their hematocrit values immediately following the birth through normal falls in erythropoietin (Epo) production, transition to adult hemoglobin, and hemodilution with somatic growth. However, this drop is more pronounced in critically ill and preterm neonates and can lead to potentially pathologic anemia that impairs tissue oxygen delivery. In this review, we highlight the mechanisms underlying physiologic anemia and anemia of prematurity and briefly review the evidence for the treatment of anemia in the neonatal population, including the use of red blood cell transfusions, erythropoietic stimulating agents, and iron supplementation.
Keywords: Anemia, neonate, anemia of prematurity, erythropoietin, iron, transfusions.
« Previous Next »
Graphical Abstract

[1]
Jopling J, Henry E, Wiedmeier SE, Christensen RD. Reference ranges for hematocrit and blood hemoglobin concentration during the neo-natal period: Data from a multihospital health care system. Pediatrics  2009; 123(2): e333-7.
 [http://dx.doi.org/10.1542/peds.2008-2654] [PMID: 19171584]

[2]
Christensen RD, Henry E, Jopling J, Wiedmeier SE. The CBC: Reference ranges for neonates. Semin Perinatol  2009; 33(1): 3-11.
 [http://dx.doi.org/10.1053/j.semperi.2008.10.010] [PMID: 19167576]

[3]
Juul SE, Vu PT, Comstock BA, et al. Effect of high-dose erythropoietin on blood transfusions in extremely low gestational age neonates. JAMA Pediatr  2020; 174(10): 933-43.
 [http://dx.doi.org/10.1001/jamapediatrics.2020.2271] [PMID: 32804205]

[4]
Yoshimoto M, Yoder MC. Birth of the blood cell. Nature  2009; 457(7231): 801-3.
 [http://dx.doi.org/10.1038/457801a] [PMID: 19212393]

[5]
Palis J. Primitive and definitive erythropoiesis in mammals. Front Physiol  2014; 5: 3.
 [http://dx.doi.org/10.3389/fphys.2014.00003] [PMID: 24478716]

[6]
Kumar R, Sinha S. Book Review-Avery’s Diseases of the Newborn.In: Gleason CA, Juul SE Eds Avery’s Diseases of the Newborn 10th ed Philadelphia: Elsevier.   2018; p. 1627.

[7]
Neubauer H, Cumano A, Müller M, Wu H, Huffstadt U, Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in defin-itive hematopoiesis. Cell  1998; 93(3): 397-409.
 [http://dx.doi.org/10.1016/S0092-8674(00)81168-X] [PMID: 9590174]

[8]
Dieterlen-Lièvre F. Intraembryonic hematopoietic stem cells. Hematol Oncol Clin North Am  1997; 11(6): 1149-71.
 [http://dx.doi.org/10.1016/S0889-8588(05)70486-X] [PMID: 9443049]

[9]
Lin CS, Lim SK, D’Agati V, Costantini F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev  1996; 10(2): 154-64.
 [http://dx.doi.org/10.1101/gad.10.2.154] [PMID: 8566749]

[10]
Christensen RD, Jopling J, Henry E, Wiedmeier SE. The erythrocyte indices of neonates, defined using data from over 12 000 patients in a multihospital health care system. J Perinatol  2008; 28(1): 24-8.
 [http://dx.doi.org/10.1038/sj.jp.7211852] [PMID: 17972890]

[11]
Pearson HA, Vertrees KM. Site of binding of chromium-51 to haemoglobin. Nature  1961; 189(4769): 1019-20.
 [http://dx.doi.org/10.1038/1891019a0] [PMID: 13733788]

[12]
Kuruvilla DJ, Widness JA, Nalbant D, et al. Estimation of adult and neonatal RBC lifespans in anemic neonates using RBCs labeled at several discrete biotin densities. Pediatr Res  2017; 81(6): 905-10.
 [http://dx.doi.org/10.1038/pr.2017.14] [PMID: 28099421]

[13]
Ohls RK, Harcum J, Li Y, Davila G, Christensen RD. Serum erythropoietin concentrations fail to increase after significant phlebotomy losses in ill preterm infants. J Perinatol  1997; 17(6): 465-7.
 [PMID: 9447534]

[14]
Keir AK, Yang J, Harrison A, Pelausa E, Shah PS, Network CN. Temporal changes in blood product usage in preterm neonates born at less than 30 weeks’ gestation in Canada. Transfusion  2015; 55(6): 1340-6.
 [http://dx.doi.org/10.1111/trf.12998] [PMID: 25652740]

[15]
Bell EF, Strauss RG, Widness JA, et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics  2005; 115(6): 1685-91.
 [http://dx.doi.org/10.1542/peds.2004-1884] [PMID: 15930233]

[16]
Kirpalani H, Bell EF, Hintz SR, et al. Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants. N Engl J Med  2020; 383(27): 2639-51.
 [http://dx.doi.org/10.1056/NEJMoa2020248] [PMID: 33382931]

[17]
Kirpalani H, Whyte RK, Andersen C, et al. The premature infants in need of transfusion (pint) study: A randomized, controlled trial of a restrictive (LOW) versus liberal (HIGH) transfusion threshold for extremely low birth weight infants. J Pediatr  2006; 149(3): 301-307.e3.
 [http://dx.doi.org/10.1016/j.jpeds.2006.05.011] [PMID: 16939737]

[18]
Bell EF. Red cell transfusion thresholds for preterm infants: Finally some answers. Arch Dis Child Fetal Neonatal Ed  2021; 102(7): 126-30.
 [PMID: 33906941]

[19]
Franz AR, Engel C, Bassler D, et al. Effects of liberal vs. restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants. JAMA  2020; 324(6): 560-70.
 [http://dx.doi.org/10.1001/jama.2020.10690] [PMID: 32780138]

[20]
Santos AMNd, Guinsburg R, Almeida MFBd, Procianoy RS, Leone
 CR, Marba STM, et al. Red blood cell transfusions are independently
  associated with intra-hospital mortality in very low birth
 weight preterm infants. J Pediatrics 2011; 159(3): 371-76-e1-3.

[21]
Mohamed A, Shah PS. Transfusion associated necrotizing enterocolitis: a meta-analysis of observational data. Pediatrics  2012; 129(3): 529-40.
 [http://dx.doi.org/10.1542/peds.2011-2872] [PMID: 22351894]

[22]
Patel RM, Knezevic A, Shenvi N, et al. Association of red blood cell transfusion, anemia, and necrotizing enterocolitis in very low-birth-weight infants. JAMA  2016; 315(9): 889-97.
 [http://dx.doi.org/10.1001/jama.2016.1204] [PMID: 26934258]

[23]
Paul DA, Mackley A, Novitsky A, Zhao Y, Brooks A, Locke RG. Increased odds of necrotizing enterocolitis after transfusion of red blood cells in premature infants. Pediatrics  2011; 127(4): 635-41.
 [http://dx.doi.org/10.1542/peds.2010-3178] [PMID: 21402638]

[24]
Song J, Dong H, Xu F, et al. The association of severe anemia, red blood cell transfusion and necrotizing enterocolitis in neonates. PLoS One  2021; 16(7), e0254810.
 [http://dx.doi.org/10.1371/journal.pone.0254810] [PMID: 34283868]

[25]
Slidsborg C, Jensen A, Forman JL, et al. Neonatal risk factors for treatment-demanding retinopathy of prematurity. Ophthalmology  2016; 123(4): 796-803.
 [http://dx.doi.org/10.1016/j.ophtha.2015.12.019] [PMID: 26854038]

[26]
Sharma A, Xin Y, Chen X, Sood BG. Early prediction of moderate to severe bronchopulmonary dysplasia in extremely premature infants. Pediatr Neonatol  2020; 61(3): 290-9.
 [http://dx.doi.org/10.1016/j.pedneo.2019.12.001] [PMID: 32217025]

[27]
Baer VL, Lambert DK, Henry E, Snow GL, Butler A, Christensen RD. Among very-low-birth-weight neonates is red blood cell transfusion an independent risk factor for subsequently developing a severe intraventricular hemorrhage? Transfusion  2011; 51(6): 1170-8.
 [http://dx.doi.org/10.1111/j.1537-2995.2010.02980.x] [PMID: 21166684]

[28]
Del Vecchio A, Henry E, D’Amato G, et al. Instituting a program to reduce the erythrocyte transfusion rate was accompanied by reduc-tions in the incidence of bronchopulmonary dysplasia, retinopathy of prematurity and necrotizing enterocolitis. J Matern Fetal Neonatal Med  2013; 26 (Suppl. 2): 77-9.
 [http://dx.doi.org/10.3109/14767058.2013.830836] [PMID: 24059559]

[29]
Dani C, Poggi C, Gozzini E, et al. Red blood cell transfusions can induce proinflammatory cytokines in preterm infants. Transfusion  2017; 57(5): 1304-10.
 [http://dx.doi.org/10.1111/trf.14080] [PMID: 28295397]

[30]
Stark MJ, Keir AK, Andersen CC. Does non-transferrin bound iron contribute to transfusion related immune-modulation in preterms? Arch Dis Child Fetal Neonatal Ed  2013; 98(5): F424-9.
 [http://dx.doi.org/10.1136/archdischild-2012-303353] [PMID: 23475935]

[31]
Whyte RK, Kirpalani H, Asztalos EV, et al. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics  2009; 123(1): 207-13.
 [http://dx.doi.org/10.1542/peds.2008-0338] [PMID: 19117884]

[32]
Shah P, Cannon DC, Lowe JR, et al. Effect of blood transfusions on cognitive development in very low birth weight infants. J Perinatol  2021; 41(6): 1412-8.
 [http://dx.doi.org/10.1038/s41372-021-00997-9] [PMID: 33911186]

[33]
Vu PT, Ohls RK, Mayock DE, et al. Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial. Pediatr Res  2021; 90(1): 109-16.
 [http://dx.doi.org/10.1038/s41390-020-01273-w] [PMID: 33432157]

[34]
Hébert PC, Wells G, Tweeddale M, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med  1997; 155(5): 1618-23.
 [http://dx.doi.org/10.1164/ajrccm.155.5.9154866] [PMID: 9154866]

[35]
Niu MT, Knippen M, Simmons L, Holness LG. Transfusion-transmitted Klebsiella pneumoniae fatalities, 1995 to 2004. Transfus Med Rev  2006; 20(2): 149-57.
 [http://dx.doi.org/10.1016/j.tmrv.2005.11.007] [PMID: 16565027]

[36]
Popovsky MA. Pulmonary consequences of transfusion: TRALI and TACO. Transfus Apheresis Sci  2006; 34(3): 243-4.
 [http://dx.doi.org/10.1016/j.transci.2006.01.005] [PMID: 16872902]

[37]
Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): An update. Blood Rev  2007; 21(6): 327-48.
 [http://dx.doi.org/10.1016/j.blre.2007.07.003] [PMID: 17804128]

[38]
Baer VL, Henry E, Lambert DK, et al. Implementing a program to improve compliance with neonatal intensive care unit transfusion guide-lines was accompanied by a reduction in transfusion rate: a pre-post analysis within a multihospital health care system. Transfusion  2011; 51(2): 264-9.
 [http://dx.doi.org/10.1111/j.1537-2995.2010.02823.x] [PMID: 20723168]

[39]
Baer VL, Lambert DK, Schmutz N, et al. Adherence to NICU transfusion guidelines: data from a multihospital healthcare system. J Perinatol  2008; 28(7): 492-7.
 [http://dx.doi.org/10.1038/jp.2008.23] [PMID: 18337739]

[40]
Chen HL, Tseng HI, Lu CC, Yang SN, Fan HC, Yang RC. Effect of blood transfusions on the outcome of very low body weight preterm infants under two different transfusion criteria. Pediatr Neonatol  2009; 50(3): 110-6.
 [http://dx.doi.org/10.1016/S1875-9572(09)60045-0] [PMID: 19579757]

[41]
Koury MJ, Bondurant MC, Atkinson JB. Erythropoietin control of terminal erythroid differentiation: maintenance of cell viability, produc-tion of hemoglobin, and development of the erythrocyte membrane. Blood Cells  1987; 13(1-2): 217-26.
 [PMID: 3478108]

[42]
Koury MJ, Bondurant MC. The mechanism of erythropoietin action. Am J Kidney Dis  1991; 18(4) (Suppl. 1): 20-3.
 [PMID: 1656733]

[43]
Yoshimura A, Misawa H. Physiology and function of the erythropoietin receptor. Curr Opin Hematol  1998; 5(3): 171-6.
 [http://dx.doi.org/10.1097/00062752-199805000-00004] [PMID: 9664155]

[44]
Silva M, Grillot D, Benito A, Richard C, Nuñez G, Fernández-Luna JL. Erythropoietin can promote erythroid progenitor survival by re-pressing apoptosis through Bcl-XL and Bcl-2. Blood  1996; 88(5): 1576-82.
 [http://dx.doi.org/10.1182/blood.V88.5.1576.1576] [PMID: 8781412]

[45]
Fahnenstich H, Dame C. Erythropoietin concentrations and erythropoiesis in newborns suffering from renal agenesis and congenital kid-ney diseases. Eur J Pediatr  1996; 155(3): 185-8.
 [http://dx.doi.org/10.1007/BF01953935] [PMID: 8929725]

[46]
Ascensao JL, Bilgrami S, Zanjani ED. Erythropoietin. Biology and clinical applications. J Pediatr Hematol Oncol  1991; 13(4): 376-87.
 [http://dx.doi.org/10.1097/00043426-199124000-00002] [PMID: 1785666]

[47]
Juul S. Erythropoietin in anemia of prematurity. J Matern Fetal Neonatal Med  2012; 25 (Suppl. 5): 80-4.
 [http://dx.doi.org/10.3109/14767058.2012.716987] [PMID: 23025776]

[48]
Batchelor EK, Kapitsinou P, Pergola PE, Kovesdy CP, Jalal DI. Iron deficiency in chronic kidney disease: Updates on pathophysiology, diagnosis, and treatment. J Am Soc Nephrol  2020; 31(3): 456-68.
 [http://dx.doi.org/10.1681/ASN.2019020213] [PMID: 32041774]

[49]
Smith R. Applications of darbepoietin-α, a novel erythropoiesis-stimulating protein, in oncology. Curr Opin Hematol  2002; 9(3): 228-33.
 [http://dx.doi.org/10.1097/00062752-200205000-00009] [PMID: 11953669]

[50]
Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer  2001; 84 (Suppl. 1): 3-10.
 [http://dx.doi.org/10.1054/bjoc.2001.1746] [PMID: 11308268]

[51]
Patel S, Ohls RK. Darbepoetin administration in term and preterm neonates. Clin Perinatol  2015; 42(3): 557-66.
 [http://dx.doi.org/10.1016/j.clp.2015.04.016] [PMID: 26250917]

[52]
Warwood TL, Ohls RK, Wiedmeier SE, et al. Single-dose darbepoetin administration to anemic preterm neonates. J Perinatol  2005; 25(11): 725-30.
 [http://dx.doi.org/10.1038/sj.jp.7211387] [PMID: 16151471]

[53]
Ohlsson A, Aher SM. Early erythropoiesis-stimulating agents in preterm or low birth weight infants. Cochrane Libr  2020; 2(2), CD004863.
 [http://dx.doi.org/10.1002/14651858.CD004863.pub6] [PMID: 32048730]

[54]
Garcia MG, Hutson AD, Christensen RD. Effect of recombinant erythropoietin on “late” transfusions in the neonatal intensive care unit: a meta-analysis. J Perinatol  2002; 22(2): 108-11.
 [http://dx.doi.org/10.1038/sj.jp.7210677] [PMID: 11896514]

[55]
Aher SM, Ohlsson A. Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants. Cochrane Libr  2019; 2(2), CD004868.
 [http://dx.doi.org/10.1002/14651858.CD004868.pub5] [PMID: 30776084]

[56]
Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev  2006; 3(3), CD004863.
 [PMID: 16856062]

[57]
Mayock DE, Xie Z, Comstock BA, Heagerty PJ, Juul SE, Consortium PENPT. High-dose erythropoietin in extremely low gestational age neonates does not alter risk of retinopathy of prematurity. Neonatology  2020; 117(5): 650-7.
 [http://dx.doi.org/10.1159/000511262] [PMID: 33113526]

[58]
Juul SE. Nonerythropoietic roles of erythropoietin in the fetus and neonate. Clin Perinatol  2000; 27(3): 527-41.
 [http://dx.doi.org/10.1016/S0095-5108(05)70037-3] [PMID: 10986627]

[59]
Juul SE, Yachnis AT, Rojiani AM, Christensen RD. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Dev Pathol  1999; 2(2): 148-58.
 [http://dx.doi.org/10.1007/s100249900103] [PMID: 9949221]

[60]
Juul SE, Stallings SA, Christensen RD. Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury. Pediatr Res  1999; 46(5): 543-7.
 [http://dx.doi.org/10.1203/00006450-199911000-00009] [PMID: 10541316]

[61]
Juul SE, Yachnis AT, Christensen RD. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev  1998; 52(3): 235-49.
 [http://dx.doi.org/10.1016/S0378-3782(98)00030-9] [PMID: 9808074]

[62]
Diao M, Qu Y, Liu H, Ma Y, Lin X. Effect of carbamylated erythropoietin on neuronal apoptosis in fetal rats during intrauterine hypoxic-ischemic encephalopathy. Biol Res  2019; 52(1): 28.
 [http://dx.doi.org/10.1186/s40659-019-0234-7] [PMID: 31084604]

[63]
Villa P, Bigini P, Mennini T, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med  2003; 198(6): 971-5.
 [http://dx.doi.org/10.1084/jem.20021067] [PMID: 12975460]

[64]
Tamura T, Aoyama M, Ukai S, Kakita H, Sobue K, Asai K. Neuroprotective erythropoietin attenuates microglial activation, including mor-phological changes, phagocytosis, and cytokine production. Brain Res  2017; 1662: 65-74.
 [http://dx.doi.org/10.1016/j.brainres.2017.02.023] [PMID: 28257780]

[65]
Bailey DM, Lundby C, Berg RMG, et al. On the antioxidant properties of erythropoietin and its association with the oxidative-nitrosative stress response to hypoxia in humans. Acta Physiol (Oxf)  2014; 212(2): 175-87.
 [http://dx.doi.org/10.1111/apha.12313] [PMID: 24811856]

[66]
Fischer HS, Reibel NJ, Bührer C, Dame C. Prophylactic early erythropoietin for neuroprotection in preterm infants: A meta-analysis. Pediatrics  2017; 139(5), e20164317.
 [http://dx.doi.org/10.1542/peds.2016-4317] [PMID: 28557760]

[67]
Juul SE, Comstock BA, Wadhawan R, et al. A randomized trial of erythropoietin for neuroprotection in preterm infants. N Engl J Med  2020; 382(3): 233-43.
 [http://dx.doi.org/10.1056/NEJMoa1907423] [PMID: 31940698]

[68]
Malla RR, Asimi R, Teli MA, Shaheen F, Bhat MA. Erythropoietin monotherapy in perinatal asphyxia with moderate to severe encephalo-pathy: a randomized placebo-controlled trial. J Perinatol  2017; 37(5): 596-601.
 [http://dx.doi.org/10.1038/jp.2017.17] [PMID: 28277490]

[69]
Juul SE, Comstock BA, Heagerty PJ, et al. High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Con-trolled Trial – Background, Aims, and Study Protocol. Neonatology  2018; 113(4): 331-8.
 [http://dx.doi.org/10.1159/000486820] [PMID: 29514165]

[70]
Zamora TG, Guiang SF III, Widness JA, Georgieff MK. Iron is prioritized to red blood cells over the brain in phlebotomized anemic new-born lambs. Pediatr Res  2016; 79(6): 922-8.
 [http://dx.doi.org/10.1038/pr.2016.20] [PMID: 26866907]

[71]
Widdowson EM, Spray CM. Chemical development in utero. Arch Dis Child  1951; 26(127): 205-14.
 [http://dx.doi.org/10.1136/adc.26.127.205] [PMID: 14857788]

[72]
American Academy of Pediatrics CoFaN. Gynecologists TACoOa.
 Guidelines for perinatal care, 7th Ed. 2014; Available from: http://simponline.it/wp-content/uploads/2014/11/GuidelinesforPerinatalCare.pdf

[73]
German KR, Vu PT, Comstock BA, et al. Enteral iron supplementation
in infants born extremely preterm and its positive correlation
 with neurodevelopment; post hoc analysis of the preterm erythropoietin
 neuroprotection trial randomized controlled trial. The Journal
 of pediatrics 2021; S0022-3476(21): 00686-7.
Rights & Permissions Print Cite
Article Metrics
110
2
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/1573396319666221121140627	Print ISSN 1573-3963
Publisher Name Bentham Science Publisher	Online ISSN 1875-6336
Current Pediatric Reviews

Neonatal Anemia

Abstract

Graphical Abstract

Related Journals

Related Books
